Indonesian Political, Business & Finance News

World Patient Safety Day: Public Urged to Actively Ensure Medication Safety

| | Source: Media Indonesia Translated from Indonesian | Social Policy
World Patient Safety Day: Public Urged to Actively Ensure Medication Safety
Image: Media Indonesia

NOVO Indonesia is inviting the public to participate actively in maintaining patient safety, specifically in ensuring the safety of medication use. This call was made in conjunction with World Patient Safety Day, observed annually on 17 September.

Patient safety pertains not only to the quality of healthcare services but also to the safety of medicines used during the treatment process. This is of particular concern to individuals undergoing long-term treatment for non-communicable diseases (NCDs), such as diabetes and obesity.

Members of the public can contribute by ensuring that medicines are obtained through proper channels, using medication according to healthcare professional recommendations, and monitoring and reporting any side effects that arise during treatment.

Dr Riyanny Meisha Tarlinan, Associate Director of Medical & Regulatory at NOVO Indonesia, stated that patient safety requires the involvement of various parties, including patients and the wider community. “Through collaboration and the active role of every party, we can collectively support a safer treatment journey for patients,” said Riyable.

According to her, NOVO’s commitment to patient safety spans from before a product is marketed until it is used by the patient. These efforts include implementing quality processes and standards, systems to ensure product authenticity, support for detecting illegal products, and post-market safety monitoring.

“For NOVO, these efforts begin with the implementation of quality processes and standards before products are marketed, systems to ensure product authenticity, efforts to support the detection of illegal products, and monitoring safety after use through Pharmacovigilance responsibilities,” she added.

Pharmacovigilance refers to the activity of monitoring drug safety after products are used by the public. This monitoring is conducted to identify and evaluate risks associated with medication use, ensuring that safety aspects are continuously monitored throughout the product life cycle.

Additionally, NOVO Indonesia implements a serialisation system as part of its product quality and safety management. The company also supports efforts to detect illegal products circulating through online channels and conducts public education regarding safe medication use.

World Patient Safety Day was established through the World Health Assembly in 2019 and is commemorated every 17 September. The observance serves as a global momentum to increase public understanding and involvement in patient safety, while encouraging efforts to reduce preventable risks in healthcare services.

In the context of medication use, patient involvement is a vital part of maintaining safety during treatment. Patients are expected not only to follow medical advice but also to ensure that the medicines used come from the correct sources and to provide information if they experience side effects.

NOVO Indonesia stated that it will continue to place patient safety as a core part of product quality and safety management at every stage of the product life cycle, from production to patient use.

The Head of the Indonesian Food and Drug Authority (BPOM), Prof Taruna Ikrar, emphasised that patient safety is non-negotiable and remains a shared obligation.

More from 17 September 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/world-patient-safety-day-public-urged-to-actively-ensure-medication-safety-1789655204)
Originally published by Media Indonesia (https://mediaindonesia.com/humaniora/934603/peringati-hari-kesehatan-dunia-masyarakat-didorong-aktif-jaga-keamanan-penggunaan-obat), translated from Indonesian
Print